Ichor Biologics
Founded
2014
2014
Status
Private
Private
Geography
United States of America based
United States of America based
Website
http://www.ichorbiologics.com/
http://www.ichorbiologics.com/
About
Ichor Biologics specializes in the development of therapeutic monoclonal antibodies to treat infectious diseases. Our company has developed a platform for characterizing and isolating pathogen-specific antibodies from convalescent patients. This platform allows us to preserve neutralizing and non-neutralizing antibody functions, thereby increasing the likelihood of in-vivo efficacy. Our initial disease targets include viral infections, such as Hantaviruses and HBV.
Business model
- Software as a Service / AI as Service (SaaS, AIaaS)
Therapeutic focus
- Immunology
- Infectious Diseases
Product type
- Biologics
Research focus
- Biology research (Target identification/validation)
- Lead Discovery
